AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 172 GBX
-0.6%
Market Closed
Updated:
May 15, 2024
AstraZeneca PLC
Depreciation & Amortization
|
AstraZeneca PLC
Depreciation & Amortization Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Depreciation & Amortization
$5.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Depreciation & Amortization
£2.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
14%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Depreciation & Amortization
$677k
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Depreciation & Amortization
$31m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Depreciation & Amortization
$259m
|
CAGR 3-Years
42%
|
CAGR 5-Years
19%
|
CAGR 10-Years
13%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Depreciation & Amortization
£89.7m
|
CAGR 3-Years
85%
|
CAGR 5-Years
65%
|
CAGR 10-Years
15%
|
See Also
What is AstraZeneca PLC's Depreciation & Amortization?
Depreciation & Amortization
5.1B
USD
5.1B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Depreciation & Amortization amounts to 5.1B USD.
What is AstraZeneca PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
1%
1%
Over the last year, the Depreciation & Amortization growth was -9%. The average annual Depreciation & Amortization growth rates for AstraZeneca PLC have been 18% over the past three years , 7% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
